PR put buyers and retail crowd pile in ahead of November earnings
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Three distinct signals are converging on PR this week. Options traders have turned notably more defensive, retail attention has spiked to an unusual high, and short interest has held near its recent doubled level. Earnings are due November 4.
Put demand jumps to a 6-week extreme
The put-call ratio hit 0.3621 on October 20, sitting 2.8 standard deviations above its 20-day mean of 0.259. That is the highest reading since early September. Over the prior three weeks, the PCR had barely moved, ranging between 0.245 and 0.267. The two-day pop to 0.360 and then 0.362 is a clear break from that range.
The 52-week low on the PCR is 0.183 and the high is 0.509, so current positioning sits in the upper third of the full-year range but is not at an extreme on an absolute basis. What matters is the pace of change: put demand doubled relative to calls in roughly 48 hours while the stock was essentially flat.
Retail attention hits a 4.5-sigma spike
Wikipedia views and ORTEX stock page traffic for Permian Resources have reached 4.5 standard deviations above their own 90-day average as of October 21. This is an attention reading, not a revenue indicator, but spikes of this magnitude in the two weeks before an earnings date often reflect retail traders positioning for a catalyst.
The timing aligns with the put-buying surge. Both signals appeared on the same day.
Short interest: elevated but stable
Short interest stands at 3.9% of the free float as of October 20, roughly where it was when the previous ORTEX note was published on October 14. Shares short have not accelerated further from the roughly 28.5 to 29 million level established around October 8 to 9. The one-week change is now 3.3%, a fraction of the near-80% weekly surge that triggered the earlier note.
The borrow market remains very loose. Availability sits at 5,404%, meaning more than fifty-four shares are available to lend for every one already out on loan. Cost to borrow is 0.38%. There is no stress in the lending market.
Analysts still raising targets
Five firms raised price targets in the past ten days. Susquehanna moved to $30 from $25 on October 20. Morgan Stanley lifted to $27 from $25 on October 15. Wells Fargo went to $28 from $27. Citigroup and Truist both raised to $28 from $24. Every recent move is an upgrade in target, none a downgrade. The consensus mean target is $25.79, close to the current price of $24.84.
T. Rowe Price added 18 million shares as of September 30, making it the largest reported institutional buyer over the period. BlackRock added just under 8 million shares over the same window.
What to watch
The November 4 earnings date is the next hard catalyst. The prior three prints produced one-day moves of +1.8%, minus 1.1%, and minus 3.8%. Watch whether the PCR holds above 0.35 in the days immediately before the report, and whether short interest pushes back toward the September 16 high of approximately 30 million shares.
Data summary
- Short interest: 3.9% of free float, 28.9 million shares (October 20)
- Put-call ratio: 0.362, z-score +2.8 vs 20-day mean (October 20)
- Retail attention z-score: +4.5 vs 90-day average (October 21)
- Borrow availability: 5,404%, cost to borrow 0.38%
- Next earnings: November 4, 2026
Stocks in this article
See the live data behind this article on ORTEX.
Open PR on ORTEX →How this article was generated
- Generated
- 21 Oct 2026, 17:09
- Data as of
- 21 Oct 2026, 17:07
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.